---
id: 100
title: Neutropenic Fever Management
category: clinical_syndromes
subcategory: neutropenic_fever
tags: [neutropenic-fever, febrile-neutropenia, ANC, antipseudomonal, empiric-therapy]
difficulty: medium
---

## Question

How is neutropenic fever managed? Use the **"High-Risk → Antipseudomonal β-Lactam + Reassess at 48-72h"** framework.

## Answer

### **Definition:**
- **Fever:** Single temp ≥38.3°C (101°F) OR ≥38°C (100.4°F) × 1 hour
- **Neutropenia:** **ANC <500** cells/μL OR ANC <1000 and expected to fall <500

### **Risk Stratification:**

**High-Risk (any of):**
- **ANC <100** (profound neutropenia)
- **Prolonged neutropenia** (expected >7 days)
- **Hemodynamic instability**
- **Acute leukemia** or **HSCT**
- **Significant comorbidities** (pneumonia, mucositis, invasive fungal infection)

**Low-Risk (all of):**
- ANC 100-500 or expected to recover quickly (<7 days)
- Hemodynamically stable
- No pneumonia, no comorbidities
- **MASCC score ≥21** (low-risk)

### **Empiric Therapy:**

**High-Risk (Inpatient IV Therapy):**

**Monotherapy (preferred):**
- **Cefepime** 2g IV q8h OR
- **Piperacillin-tazobactam** 4.5g IV q6h OR
- **Meropenem** 1g IV q8h (if ESBL/resistant GNB risk)

**Add Vancomycin if:**
- Hemodynamic instability
- Pneumonia
- Skin/soft tissue infection (MRSA concern)
- Mucositis  (MRSA can be part of oral flora)
- Blood culture with Gram-positive cocci

**Low-Risk (Outpatient Oral Therapy):**
- **Ciprofloxacin 750mg PO BID + amoxicillin-clavulanate 875mg PO BID**
- Close follow-up (daily or every other day)

### **Reassessment at 48-72 Hours:**

**Clinically Stable + Cultures Negative:**
- **Continue same regimen** until ANC recovery (ANC >500)

**Clinically Stable + Cultures Positive:**

- **De-escalate** to targeted therapy based on sensitivities

**Persistent Fever + Cultures Negative:**
- **Continue antibiotics** (don't stop)
- **Consider adding antifungal** (voriconazole, liposomal amphotericin B) if:
  - Persistent fever >4-7 days despite antibiotics
  - High-risk for invasive fungal infection (IFI)
  - CT chest findings (nodules, halo sign)

## Key Points

### **When to Add Empiric Antifungal:**
- **Persistent fever** (>4-7 days) despite broad-spectrum antibiotics
- **High-risk for IFI:** Prolonged neutropenia (>10 days), HSCT, acute leukemia
- **CT chest:** Nodules, halo sign, cavitation (suggestive of *Aspergillus*)
- **Positive fungal biomarkers:** Galactomannan, β-D-glucan

**Empiric Antifungal Options:**
- **Voriconazole** 6mg/kg IV q12h × 2 → 4mg/kg q12h OR
- **Liposomal amphotericin B** 3-5 mg/kg IV daily OR
- **Caspofungin** 70mg IV × 1 → 50mg daily

### **Clinical Pearls:**
- **Antipseudomonal β-lactam** (cefepime, pip-tazo, meropenem) first-line
- **Don't add vancomycin empirically** unless specific indication
- **Continue antibiotics** until ANC >500 (even if afebrile, cultures negative)
- **Add antifungal** if persistent fever >4-7 days despite antibiotics
- **Low-risk patients** can be managed outpatient (MASCC score ≥21)
- **G-CSF** consider if prolonged neutropenia or high-risk

## Sources

- [IDSA: Febrile Neutropenia Guidelines 2024]
- [NCCN: Prevention and Treatment of Cancer-Related Infections 2024]

## Media

N/A
